Thrivent Financial for Lutherans’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$165M Sell
469,965
-76,072
-14% -$27.1M 0.32% 56
2025
Q4
$179M Sell
546,037
-6,575
-1% -$2.09M 0.32% 51
2025
Q3
$156M Buy
552,612
+22,354
+4% +$6.48M 0.31% 57
2025
Q2
$148M Buy
530,258
+65,560
+14% +$18.6M 0.32% 53
2025
Q1
$145M Sell
464,698
-29,384
-6% -$8.68M 0.32% 59
2024
Q4
$129M Buy
494,082
+4,997
+1% +$1.48M 0.25% 80
2024
Q3
$158M Sell
489,085
-136,220
-22% -$44.6M 0.3% 64
2024
Q2
$195M Buy
625,305
+36,019
+6% +$10.6M 0.39% 37
2024
Q1
$168M Buy
589,286
+124,167
+27% +$36.3M 0.34% 56
2023
Q4
$134M Buy
465,119
+32,457
+8% +$8.84M 0.29% 78
2023
Q3
$116M Buy
432,662
+161,456
+60% +$40.3M 0.28% 85
2023
Q2
$60.2M Buy
271,206
+4,366
+2% +$1.01M 0.14% 200
2023
Q1
$64.5M Sell
266,840
-74,924
-22% -$18.4M 0.16% 182
2022
Q4
$89.8M Sell
341,764
-99,825
-23% -$26.8M 0.23% 111
2022
Q3
$99.5M Buy
441,589
+29,123
+7% +$7.06M 0.27% 82
2022
Q2
$100M Sell
412,466
-69,859
-14% -$17.1M 0.27% 80
2022
Q1
$117M Sell
482,325
-94,224
-16% -$21.6M 0.23% 106
2021
Q4
$130M Buy
576,549
+77,323
+15% +$16.3M 0.25% 95
2021
Q3
$106M Sell
499,226
-2,650
-0.5% -$610K 0.22% 115
2021
Q2
$122M Sell
501,876
-26,895
-5% -$6.62M 0.25% 95
2021
Q1
$132M Buy
528,771
+93,565
+21% +$22.3M 0.29% 76
2020
Q4
$100M Buy
435,206
+37,564
+9% +$8.66M 0.23% 105
2020
Q3
$101M Buy
397,642
+37,051
+10% +$9.18M 0.27% 79
2020
Q2
$84.9M Buy
360,591
+232,130
+181% +$53M 0.25% 91
2020
Q1
$26M Sell
128,461
-66,129
-34% -$14.4M 0.09% 258
2019
Q4
$46.9M Sell
194,590
-8,920
-4% -$1.97M 0.13% 190
2019
Q3
$39.4M Sell
203,510
-31,426
-13% -$6.03M 0.12% 188
2019
Q2
$43.3M Sell
234,936
-1,464
-0.6% -$262K 0.13% 191
2019
Q1
$44.9M Buy
236,400
+2,327
+1% +$444K 0.14% 186
2018
Q4
$45.6M Buy
234,073
+21,268
+10% +$4.15M 0.16% 155
2018
Q3
$44.1M Buy
212,805
+13,419
+7% +$2.64M 0.14% 180
2018
Q2
$36.8M Sell
199,386
-9,153
-4% -$1.62M 0.12% 174
2018
Q1
$35.6M Sell
208,539
-12,256
-6% -$2.25M 0.12% 154
2017
Q4
$38.4M Buy
220,795
+5,814
+3% +$1.03M 0.13% 157
2017
Q3
$40.1M Buy
214,981
+96,639
+82% +$17.1M 0.14% 153
2017
Q2
$20.4M Buy
118,342
+61,212
+107% +$9.96M 0.08% 229
2017
Q1
$9.37M Sell
57,130
-166,760
-74% -$27.7M 0.04% 410
2016
Q4
$32.7M Sell
223,890
-173,060
-44% -$26M 0.15% 154
2016
Q3
$66.2M Sell
396,950
-92,978
-19% -$15.7M 0.3% 90
2016
Q2
$74.5M Sell
489,928
-5,232
-1% -$813K 0.36% 66
2016
Q1
$74.2M Sell
495,160
-16,810
-3% -$2.5M 0.36% 66
2015
Q4
$83.1M Sell
511,970
-48,390
-9% -$7.61M 0.4% 56
2015
Q3
$77.5M Buy
560,360
+25,010
+5% +$3.94M 0.41% 55
2015
Q2
$82.2M Buy
535,350
+22,470
+4% +$3.6M 0.45% 52
2015
Q1
$82M Sell
512,880
-66,020
-11% -$10.4M 0.45% 53
2014
Q4
$92.2M Buy
578,900
+13,200
+2% +$2.06M 0.51% 46
2014
Q3
$79.5M Buy
565,700
+264,010
+88% +$34.5M 0.46% 53
2014
Q2
$35.7M Buy
301,690
+266,262
+752% +$30.8M 0.2% 120
2014
Q1
$4.37M Buy
35,428
+1,350
+4% +$164K 0.03% 469
2013
Q4
$3.89M Sell
34,078
-124,800
-79% -$14.2M 0.02% 485
2013
Q3
$17.8M Sell
158,878
-20,514
-11% -$2.22M 0.11% 201
2013
Q2
$17.7K Buy
+179,392
New +$18.6M 0.11% 204

Other funds holding AMGN

Thrivent Financial for Lutherans's AMGN Position: Q1 2026 in Review

Thrivent Financial for Lutherans reduced its Amgen (AMGN) stake by 14% in Q1 2026, selling an estimated $27.1M and leaving 469,965 shares worth $165M. The position accounts for 0.32% of the portfolio, ranked #56.

Thrivent Financial for Lutherans first reported a position in AMGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $195M in Q2 2024. 3,127 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Thrivent Financial for Lutherans held 469,965 shares of Amgen worth $165M as of Q1 2026.
  • Thrivent Financial for Lutherans sold 76,072 Amgen shares in Q1 2026, an estimated $27.1M.
  • Amgen made up 0.32% of Thrivent Financial for Lutherans's portfolio in Q1 2026, its #56 holding.
  • Thrivent Financial for Lutherans first reported a position in Amgen in Q2 2013 and has held it in 52 quarters since.
  • Thrivent Financial for Lutherans's Amgen position peaked at $195M in Q2 2024.
  • 3,127 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Thrivent Financial for Lutherans's 13F filing for Q1 2026, filed 1 May 2026.